Silobreaker.com
360° SearchNetworkHot SpotsTrends
 
Advanced Search Options >>
Saturday, November 21, 2009 10:13 PM

Larry Biegelsen

Type: Person
Name: Larry Biegelsen
First Reported 11/17/2009 - Updated 11/17/2009 - 1 Documents (in Medicine)
Device offers hope to the sickest heart failure patients.ORLANDO, Fla. -- A new kind of implanted heart pump helps patients in the end stages of heart failure live longer. Instead of imitating the heart's natural pumping, it pushes blood continuously ... [Forbes.com via MSN Money - 11/17/2009]
First Reported 10/29/2009 - Updated 10/29/2009 - 1 Documents
Alcon Inc (ACL)Q3 2009 Earnings CallExecutivesDoug MacHatton - VP, Treasury and Investor and Public RelationsKevin Buehler - President and CEORick Croarkin - SVP and CFODr. Sabri Markabi - SVP of Research and Development and CMOAnalystAmit Bhalla - C ... [Seeking Alpha - 10/29/2009]
First Reported 11/02/2009 - Updated 11/02/2009 - 1 Documents
Abbott Laboratories Inc - Click to view image in its original context
Abbott Laboratories Inc
NATICK, Mass. - Medical device maker Boston Scientific said Monday it received European marketing approval for its latest drug-coated stent technology, which prevents blocked arteries.The company said it will begin marketing its Promus Element stent in ... [CNBC - 11/02/2009]
First Reported 11/03/2009 - Updated 11/03/2009 - 1 Documents
Johnson & Johnson - Click to view image in its original context
Johnson & Johnson
(Adds details throughout.)DOW JONES NEWSWIRES Johnson & Johnson (JNJ) announced plans to lay off as much as 8,400 employees worldwide as part of a movement to save up to $1.7 billion in 2011.The New Brunswick, N.J., healthcare giant said it would achieve ... [CNN Money - 11/03/2009]
First Reported 11/03/2009 - Updated 11/03/2009 - 1 Documents (in Health)
HEALTHCARE giant Johnson & Johnson has announced plans to lay off as many as 8200 employees worldwide as part of a plan to save up to $US1.7 billion ($1.9bn) in 2011, citing economic and regulatory challenges.The company said it would achieve the cost ... [The Australian - 11/03/2009]
First Reported 11/06/2009 - Updated 11/06/2009 - 1 Documents (in Conflicts & Crime)
Boston Scientific Corporation - Click to view image in its original context
Boston Scientific Corporation
BOSTONSCIENTIFIC/ (UPDATE 4):UPDATE 4- * Reaches agreement with U.S. DOJ over Guidant advisories* To pay $296 million as part of deal* Will record Q3 charge of $294 million* Sees 2009 EPS of 75-79 cents, excluding items* Shares rise 1.2 pct (Adds HHS ... [Forbes.com - 11/06/2009]
First Reported 11/09/2009 - Updated 11/09/2009 - 1 Documents (in Market News)
William Weldon - Click to view image in its original context
William Weldon
Johnson & Johnson announced Tuesday that it will reduce its global workforce by 6 percent to 7 percent by cutting as many as 8400 jobs, and restructure its business to achieve savings of $1.4 billion to $1.7 billion by 2011. The company said that the ... [National AIDS Treatment Advocacy Project - 11/09/2009]
First Reported 10/20/2009 - Updated 10/20/2009 - 1 Documents (in Internet & IT)
BOSTON -(Dow Jones)- Shares of Boston Scientific Corp. (BSX) dropped Tuesday after the company pointing to challenges facing markets for its top heart devices, implantable defibrillators and drug-coated stents.The Natick, Mass., company issued weaker ... [Nasdaq - 10/20/2009]

Quotes

Commenting on the news, Wells Fargo analyst Larry Biegelsen said the rationale for the latest job cuts was "less clear to us compared to the one back in 2007" at which time the company 'was facing a number of major patent expirations in its pharmaceutical business.'
...was facing a number of major patent expirations in its pharmaceutical business and challenges in its drug-eluting stent business,' Biegelsen said. "in addition, when the company conducted its last restructuring in 2007, it stated that the street already modeled cost cuts and therefore, it did not expect the restructuring to increase eps estimates" the analyst said, adding that it will look for similar color from management on the conference callcall at 9 a.m. ET

More Content

All (23) | News (22) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0)
sort by: Date | Relevance
Johnson & Johnson Q2 2007 Earnings Call Tra... [Seeking Alpha - 11/18/2009]
New Heart Pump Extends Lives [Forbes.com via MSN Money - 11/17/2009]
UPDATE: Merck, Abbott Rise After Cholesterol-Dr... [CNN Money - 11/16/2009]
Johnson & Johnson Q3 2009 Earnings Call Tra... [Seeking Alpha - 11/16/2009]
Medtronic, Inc. F1Q10 (Qtr End 07/31/09) Earnin... [Seeking Alpha - 11/12/2009]
Analysts speculate on upcoming findings of Zeti... [PSL Group - 11/10/2009]
Johnson & Johnson to cut up to 8400 jobs [National AIDS Treatment Advocacy Project - 11/09/2009]
Boston Sci to pay $296 mln to settle US probe [Forbes.com - 11/06/2009]
Johnson & Johnson to cut 8200 jobs [The Australian - 11/03/2009]
2nd UPDATE: J&J To Cut Up To 7% Of Work For... [Nasdaq - 11/03/2009]
Merck/Schering Cholesterol Drugs At Another Cro... [Nasdaq - 11/03/2009]
UPDATE: J&J To Cut Up To 7% Of Work Force I... [CNN Money - 11/03/2009]
New Boston Scientific stent approved in Europe [CNBC - 11/02/2009]
Allergan Q3 2009 Earnings Call Transcript [Seeking Alpha - 10/30/2009]
UPDATE: Allergan 3Q Profit Rises 8.3% With Boto... [Nasdaq - 10/29/2009]
Alcon Inc Q3 2009 Earnings Conference Call [Seeking Alpha - 10/29/2009]
Edwards Lifesciences Corporation Q3 2009 Earnin... [Seeking Alpha - 10/22/2009]
UPDATE Boston Sci Shares Fall As Top Products F... [Easy Bourse - 10/20/2009]
UPDATE: Boston Sci Shares Fall As Top Products ... [Nasdaq - 10/20/2009]
Boston Sci Shares Fall As Challenges Rise For T... [Nasdaq - 10/20/2009]
Johnson & Johnson Q3 2009 [Seeking Alpha - 10/14/2009]
Johnson & Johnson Q3 2009 Earnings Call Tra... [Seeking Alpha - 10/13/2009]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Network
Trends

Blogs

sort by: Date | Relevance
Analysts Like J&J’s Deal for Cougar [WSJ.com: Health Blog - 05/22/2009]
Johnson & Johnson said late yesterday that it’s buying Cougar Biotechnology for about $894 million, or $43 a share. That’s a 16% premium to where the stock closed ...
1

  •  
  •  
  •